| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA918317 | F | Antimalarial activity against Plasmodium vinckei petteri infected intraperitoneally dosed Swiss Albino mice (Mus musculus) | Plasmodium vinckei petteri | 6 | organism-based format | Scientific Literature | ||
| 2. | ALA918318 | F | Antimalarial activity against Plasmodium vinckei petteri infected orally dosed Swiss Albino mice (Mus musculus) | Plasmodium vinckei petteri | 6 | organism-based format | Scientific Literature | ||
| 3. | ALA918319 | F | Antimalarial activity against Plasmodium vinckei petteri infected subcutaneously dosed Swiss Albino mice (Mus musculus) | Plasmodium vinckei petteri | 6 | organism-based format | Scientific Literature | ||
| 4. | ALA918309 | F | Antimalarial activity against Plasmodium vinckei petteri infected mice (Mus musculus) at 13 mg/kg/day, peroral administered 4 days after infection for 4 days | Plasmodium vinckei petteri | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA918311 | F | Antimalarial activity against Plasmodium vinckei petteri infected mice (Mus musculus) at 5 mg/kg/day, peroral administered 4 days after infection for 4 days | Plasmodium vinckei petteri | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA905877 | F | Antimalarial activity against Plasmodium vinckei petteri 279BY infected intraperitoneal dosed Swiss mice (Mus musculus) | Plasmodium vinckei petteri | 10 | organism-based format | Scientific Literature | ||
| 7. | ALA905878 | F | Antimalarial activity against Plasmodium vinckei petteri 279BY infected peroral dosed Swiss mice (Mus musculus) | Plasmodium vinckei petteri | 10 | organism-based format | Scientific Literature | ||
| 8. | ALA2061708 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitaemia at 10 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 by Giemsa staining relative to control | Plasmodium vinckei petteri | 2 | organism-based format | Scientific Literature | ||
| 9. | ALA2061709 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitaemia at 1 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 by Giemsa staining relative to control | Plasmodium vinckei petteri | 2 | organism-based format | Scientific Literature | ||
| 10. | ALA2061710 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitaemia at 5 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 by Giemsa staining relative to control | Plasmodium vinckei petteri | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA2061711 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as suppression of parasitaemia at 2.5 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 by Giemsa staining relative to control | Plasmodium vinckei petteri | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA2061712 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in ip dosed CD mouse assessed as suppression of parasitaemia administered from day 0 to day 3 and measured on day 4 by Giemsa staining | Plasmodium vinckei petteri | 2 | organism-based format | Scientific Literature | ||
| 13. | ALA2061713 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as survival of infected mouse at 10 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 (Rvb = 9.5 days) | Plasmodium vinckei petteri | 2 | organism-based format | Scientific Literature | ||
| 14. | ALA2061714 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as survival of infected mouse at 1 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 (Rvb = 9.5 days) | Plasmodium vinckei petteri | 2 | organism-based format | Scientific Literature | ||
| 15. | ALA2061715 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as survival of infected mouse at 5 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 (Rvb = 9.5 days) | Plasmodium vinckei petteri | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA2061716 | F | Antiplasmodial activity Plasmodium vinckei petteri infected in CD mouse assessed as survival of infected mouse at 2.5 mg/kg/day, ip administered from day 0 to day 3 and measured on day 4 (Rvb = 9.5 days) | Plasmodium vinckei petteri | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA2067046 | F | Antimalarial activity against Plasmodium vinckei petteri 279BY infected in ip dosed Swiss mouse assessed as reduction in parasitemia administered QD for 4 days measured on day 5 | Plasmodium vinckei petteri | 18 | organism-based format | Scientific Literature | ||
| 18. | ALA2067047 | F | Antimalarial activity against Plasmodium vinckei petteri 279BY infected in po dosed Swiss mouse assessed as reduction in parasitemia administered QD for 4 days measured on day 5 | Plasmodium vinckei petteri | 18 | organism-based format | Scientific Literature | ||
| 19. | ALA2067048 | F | Ratio of ED50 for Plasmodium vinckei petteri 279BY infected in ip dosed Swiss mouse to ED50 for Plasmodium venckei petteri 279BY infected in po dosed Swiss mouse | Plasmodium vinckei petteri | 11 | organism-based format | Scientific Literature | ||
| 20. | ALA1023753 | F | Antimalarial activity against Plasmodium vinckei petteri 279BY infected Swiss mice (Mus musculus) at daily intraperitoneal dose for 4 days | Plasmodium vinckei petteri | 12 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!